Related references
Note: Only part of the references are listed.Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease
Hasan Kaya et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2014)
The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon
Gokhan Aksan et al.
CORONARY ARTERY DISEASE (2014)
2014 Evidence-based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) (vol 311, pg 507, 2014)
P. A. James
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease
Mehmet Erturk et al.
JOURNAL OF CARDIOLOGY (2014)
Fractional Flow Reserve-Guided PCI for Stable Coronary Artery Disease
Bernard De Bruyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
Paul A. James et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Increased serum resistin levels in patients with coronary slow-flow phenomenon
A. Canga et al.
HERZ (2013)
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
Tania Romacho et al.
MEDIATORS OF INFLAMMATION (2013)
Coronary Slow Flow - Prevalence and Clinical Correlations -
Beau M. Hawkins et al.
CIRCULATION JOURNAL (2012)
Acute ischemia manifestation in a patient with coronary slow flow phenomenon
Blendi Horjeti et al.
JOURNAL OF ELECTROCARDIOLOGY (2012)
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
ST/T wave changes during acute coronary syndrome presentation in patients with the coronary slow flow phenomenon
Natalie Cutri et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
EUROPEAN HEART JOURNAL (2011)
Visfatin (Nampt) and Ghrelin as Novel Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes
N. P. E. Kadoglou et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Coronary slow flow phenomenon: A local or systemic disease?
Xiao Wang et al.
MEDICAL HYPOTHESES (2010)
Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: Long-term clinical and functional prognosis
Gabriele Fragasso et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Cardiorespiratory capacity is associated with favourable cardiovascular risk profile in patients with Type 2 diabetes
Nikolaos P. E. Kadoglou et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2009)
Clinical and coronary angiographic characteristics of patients with coronary slow flow
Hueseyin Yilmaz et al.
ACTA CARDIOLOGICA (2008)
Oxidative stress parameters in patients with slow coronary flow
Yasar Enli et al.
ADVANCES IN THERAPY (2008)
Association of paraoxonase activity and coronary blood flow
Ali Yildiz et al.
ATHEROSCLEROSIS (2008)
Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions - Experience at a single center
Cevat Kirma et al.
CIRCULATION JOURNAL (2008)
Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias
Shoaib Saya et al.
CLINICAL CARDIOLOGY (2008)
Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow
Jian-Jun Li et al.
CLINICA CHIMICA ACTA (2007)
Pre-B cell colony-enhancing Factor/Visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities
Fabia Brentano et al.
ARTHRITIS AND RHEUMATISM (2007)
Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow
Irfan Barutcu et al.
ANGIOLOGY (2007)
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2
Su-Ryun Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus
Kohzo Takebayashi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Coronary flow reserve is impaired in patients with slow coronary flow
Dogan Erdogan et al.
ATHEROSCLEROSIS (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis -: Possible role in inflammation and plaque destabilization
Tuva B. Dahl et al.
CIRCULATION (2007)
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties
Alexander R. Moschen et al.
JOURNAL OF IMMUNOLOGY (2007)
Is slow coronary flow associated with inflammation?
JJ Li et al.
MEDICAL HYPOTHESES (2006)
Should slow coronary flow be considered as a coronary syndrome?
JJ Li et al.
MEDICAL HYPOTHESES (2006)
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
MP Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Impaired left ventricle filling in slow coronary flow phenomenon: An echo-Doppler study
AT Sezgin et al.
ANGIOLOGY (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Elevated plasma endothelin-1 levels in coronary sinus during rapid right atrial pacing in patients with slow coronary flow
H Pekdemir et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Comparison of exercise QRS amplitude changes in patients with slow coronary flow versus significant coronary stenosis
M Turkmen et al.
JAPANESE HEART JOURNAL (2004)
Diffuse intimal thickening of coronary arteries in slow coronary flow
VG Cin et al.
JAPANESE HEART JOURNAL (2003)
Minireview: Adiposity, inflammation, and atherogenesis
CJ Lyon et al.
ENDOCRINOLOGY (2003)
Vascular endothelial function in patients with slow coronary flow
AT Sezgin et al.
CORONARY ARTERY DISEASE (2003)
Share Paper
